DrugDashboards
← Home
Manufacturing facility

Lupin Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step β€” so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Unit-2, Plot No. M-2 and M-2-A, Special Economic Zone Phase II, Misc. Zone, Apparel Park, Dist. Dhar, Pithampur, Madhya Pradesh 454775, India (IND)
Operations here
manufacturepack
FDA identifiers
FEI 3007549629 Β· DUNS 863645527

Recent inspection flagged official action

FDA classified an inspection here as OAI (official action indicated) within the last two years β€” the strongest public warning signal a facility gets. This plant is listed on labels for 21 drugs. A supply problem here can ripple to all of them.

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • OAIDrug Quality Assurance2025-07-17
  • OAIDrug Quality Assurance2019-01-25
  • OAIDrug Quality Assurance2017-05-19
  • OAIDrug Quality Assurance2015-01-23
  • NAIDrug Quality Assurance2012-06-22
  • VAIDrug Quality Assurance2009-11-18

Drugs this plant is listed as making

21 distinct drugs across 98 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.

Lupin Limited β€” facility profile Β· DrugDashboards